Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Karakulska-Prystupiuk

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|September 5, 2018
Pericarditis in Patients With Chronic Graft-vs-Host DiseaseE Karakulska-Prystupiuk, G Basak, J Dwilewicz-Trojaczek, et al.
Transplantation Proceedings|September 5, 2018
Frequency of Pathologic Changes in the Oral Cavity in Patients Subjected to Long-term Pharmacologic Immunosuppressive Therapy After Kidney, Liver, and Hematopoietic Cell TransplantationM Osiak, D Szubińska-Lelonkiewicz, P Wychowański, et al.
Advances in Medical Sciences|April 27, 2007
Transient oral cavity and skin complications after mucositis preventing therapy (palifermin) in a patient after allogeneic PBSCT. Case historyA Grzegorczyk-Jaźwińska, I Kozak, E Karakulska-Prystupiuk, et al.
Transplantation Proceedings|August 7, 2016
Azacitidine Use After Allogeneic Stem Cell Transplantation-Results From the Polish Adult Leukemia GroupJ Drozd-Sokołowska, L Gil, A Waszczuk-Gajda, et al.
Transplantation Proceedings|September 5, 2018
Azacitidine for Relapse After Allogeneic Stem Cell Transplantation-Single-Center StudyE Karakulska-Prystupiuk, J Drozd-Sokołowska, A Waszczuk-Gajda, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|September 5, 2018
Pericarditis in Patients With Chronic Graft-vs-Host DiseaseE Karakulska-Prystupiuk, G Basak, J Dwilewicz-Trojaczek, et al.
Transplantation Proceedings|September 5, 2018
Frequency of Pathologic Changes in the Oral Cavity in Patients Subjected to Long-term Pharmacologic Immunosuppressive Therapy After Kidney, Liver, and Hematopoietic Cell TransplantationM Osiak, D Szubińska-Lelonkiewicz, P Wychowański, et al.
Advances in Medical Sciences|April 27, 2007
Transient oral cavity and skin complications after mucositis preventing therapy (palifermin) in a patient after allogeneic PBSCT. Case historyA Grzegorczyk-Jaźwińska, I Kozak, E Karakulska-Prystupiuk, et al.
Transplantation Proceedings|August 7, 2016
Azacitidine Use After Allogeneic Stem Cell Transplantation-Results From the Polish Adult Leukemia GroupJ Drozd-Sokołowska, L Gil, A Waszczuk-Gajda, et al.
Transplantation Proceedings|September 5, 2018
Azacitidine for Relapse After Allogeneic Stem Cell Transplantation-Single-Center StudyE Karakulska-Prystupiuk, J Drozd-Sokołowska, A Waszczuk-Gajda, et al.
Pageof 1